Anebulo Pharmaceuticals Stock Price Patterns
| ANEB Stock | USD 0.88 0.01 0.57% |
Momentum 24
Sell Stretched
Oversold | Overbought |
EPS Estimate Next Quarter (0.13) | EPS Estimate Current Year (0.48) | EPS Estimate Next Year (0.46) | Wall Street Target Price 3 | EPS Estimate Current Quarter (0.12) |
Using Anebulo Pharmaceuticals hype-based prediction, you can estimate the value of Anebulo Pharmaceuticals from the perspective of Anebulo Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Anebulo Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Anebulo because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Anebulo Pharmaceuticals after-hype prediction price | USD 0.77 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Anebulo Pharmaceuticals Basic Forecasting Models to cross-verify your projections. Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Anebulo Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Anebulo Pharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of Anebulo Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Anebulo Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Anebulo Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Anebulo Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Anebulo Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Anebulo Pharmaceuticals' historical news coverage. Anebulo Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.04 and 6.95, respectively. We have considered Anebulo Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Anebulo Pharmaceuticals is extremely dangerous at this time. Analysis and calculation of next after-hype price of Anebulo Pharmaceuticals is based on 3 months time horizon.
Anebulo Pharmaceuticals Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Anebulo Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Anebulo Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Anebulo Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.52 | 6.18 | 0.11 | 0.03 | 10 Events / Month | 5 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.88 | 0.77 | 12.00 |
|
Anebulo Pharmaceuticals Hype Timeline
Anebulo Pharmaceuticals is presently traded for 0.88. The entity has historical hype elasticity of -0.11, and average elasticity to hype of competition of 0.03. Anebulo is forecasted to decline in value after the next headline, with the price expected to drop to 0.77. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -12.0%, whereas the daily expected return is presently at -1.52%. The volatility of related hype on Anebulo Pharmaceuticals is about 34333.33%, with the expected price after the next announcement by competition of 0.91. About 41.0% of the company shares are held by company insiders. The book value of Anebulo Pharmaceuticals was presently reported as 0.24. The company recorded a loss per share of 0.22. Anebulo Pharmaceuticals had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 10 days. Check out Anebulo Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Anebulo Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Anebulo Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Anebulo Pharmaceuticals' future price movements. Getting to know how Anebulo Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Anebulo Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| TLSA | Tiziana Life Sciences | 0.08 | 8 per month | 0.00 | (0.06) | 7.41 | (5.81) | 21.81 | |
| IMMX | Immix Biopharma | 0.26 | 7 per month | 4.31 | 0.14 | 15.04 | (8.41) | 28.79 | |
| WHWK | Whitehawk Therapeutics | (0.07) | 7 per month | 3.80 | 0.05 | 6.98 | (6.67) | 21.49 | |
| ZNTL | Zentalis Pharmaceuticals Llc | 0.04 | 7 per month | 4.23 | 0.1 | 17.36 | (9.54) | 48.58 | |
| COYA | Coya Therapeutics Common | (0.02) | 4 per month | 0.00 | (0.14) | 4.69 | (5.36) | 18.45 | |
| PLRX | Pliant Therapeutics | 0.02 | 5 per month | 0.00 | (0.16) | 4.58 | (6.71) | 22.72 | |
| CLNN | Clene Inc | (0.11) | 13 per month | 0.00 | (0.1) | 10.11 | (15.07) | 47.42 | |
| MGNX | MacroGenics | 0.03 | 8 per month | 3.78 | 0.02 | 6.83 | (6.25) | 23.75 | |
| ESLA | Estrella Immunopharma | (0.06) | 5 per month | 0.00 | (0.1) | 12.21 | (15.49) | 50.95 | |
| OKYO | OKYO Pharma Ltd | 0.01 | 6 per month | 0.00 | (0.01) | 10.99 | (8.25) | 34.51 |
Anebulo Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Anebulo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Anebulo using various technical indicators. When you analyze Anebulo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Anebulo Pharmaceuticals Predictive Indicators
The successful prediction of Anebulo Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Anebulo Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Anebulo Pharmaceuticals based on analysis of Anebulo Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Anebulo Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Anebulo Pharmaceuticals's related companies. | 2025 | 2026 (projected) | PB Ratio | 4.8 | 4.56 | Capex To Depreciation | 7.0E-6 | 6.0E-6 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| VTI | Vanguard Total Stock | |
| RIOT | Riot Blockchain | |
| TSLA | Tesla Inc |
Complementary Tools for Anebulo Stock analysis
When running Anebulo Pharmaceuticals' price analysis, check to measure Anebulo Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anebulo Pharmaceuticals is operating at the current time. Most of Anebulo Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Anebulo Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anebulo Pharmaceuticals' price. Additionally, you may evaluate how the addition of Anebulo Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |